IFNA2 and viral infectious disease: In particular, animal studies have evaluated the efficacy of low-dose oral IFN-α treatment in many animal species, such as rodents, ruminants, pigs, horses, dogs and cats, in order to treat viral infections and immune-mediated disorders.